维普期刊资源整合服务平台（V6.5）

35篇 您的检索式：作者名="Tamasawa"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Serum Cystatin C in diabetic patients : not only an indicator for renal dysfunction in patients with overt nephropathy but also a predictor for cardiovascular events in patients without nephropathy 显示文摘	Ogawa Y GotoT Tamasawa N	2008	Diabetes research and clinical practice2008，79，2：	1
2	Plasma levels of soluble vascular adhesion molecule-1 and cholesterol oxidation product in type 2 diabetic patients with nephropathy显示文摘	Murakami H Tamasawa N Matsui J	2001	J Atheroscler Thromb2001，8，1：	1
3	Clofibrate,a peroxisome-prolfferator,enhances reverse cholesterol transport through cytochrome P450 activation and oxysterol generation显示文摘	Guan JZ Tamasawa N Murakami H	2003	Tohoku J Exp Med2003，201，4：	1
4	Reduction of paraoxonase-1 activi- ty may contribute the qualitative impairment of HDL particles in patients with type 2 diabetes显示文摘	Murakami H Tanabe J Tamasawa N	2013	Diabetes Res Clin Pract2013，99，1：	1
5	Clofibrate, a reverse cholesterol transport through cytochrome p450 activation and oxysterol generation显示文摘	Guan JZ Tamasawa N Murakami peroxisome-proliferat or enhances H etal	2003	J Exp Med2003，201，4：	1
6	Effect of doxazosin on the size of LDL particle in the type 2 diabetic patients with hypertension 显示文摘	Tamasawa N Matsui J Ogawa Y	2000	Diabetes Complications2000，14，3：	1
7	Identification of homozygous lipoprotein lipase gene mutation in a woman with recurrent aggravation of hypertriglyceridaemia induced by pregnancy显示文摘	SUGA S TAMASAWA N KINPAPA I	1998	J Intern Med1998，243，4：	1
8	Reduction of oxysterol levels up-regulates HMG-CoA reductase activity in rat liver显示文摘	Naoki Tamasawa Makoto Hayakari Hiroshi Murakami Jun Matsui Toshihiro Suda	1997	Atherosclerosis1997，，2：	1
9	Effect of doxazosin on the size of LDL particle in the type 2 diabetic patients with hypertension显示文摘	Tamasawa N Matsui J Ogawa Y	2000	J Diabetes Complications2000，14，3：	1
10	Clofibrate, a peroxisome-proliferator,enhances reverse cholesterol transport through cytochrome P450 activation and oxysterol generation 显示文摘	Guan JZ Tamasawa N Murakami H	2003	Tohoku J Exp Med2003，201，4：	1
11	Effect of hemodialysis on plasma glucose profile and plasma level of liraglutide in patients with type 2 diabetes mellitus and end-stage renal disease:a pilot study显示文摘	Osonoi T Saito M Tamasawa A	2014	PLo S One2014，9，11：	1
12	Serum cystatin C in diabetic patients not only anindicator for renal dysfunction in patients with overt nephropathy but also a predictor for cardiovascular events in patients without nephropathy显示文摘	Ogawa Y Goto T Tamasawa N	2008	Diabetes Res Clin Pract2008，79，2：	1
13	Plasma levels of soluble vascular adhesion molecule - 1 and cholesterol oxidation product in type 2 diabetic patients with nephropathy显示文摘	Murakami H Tamasawa N Matsui J	2001	Journal of atherosclerosis and throbosis2001，8，1：	1
14	Serum Cystatin C in diabetic patients,not only an indicator for renal dysfunction in patients with overt nephropathy but also a predictor for cardiovascular events in patients without nephropathy显示文摘	Ogawa Y Goto T Tamasawa N		0，，02：	1
15	Serum cystatin C in diabetic patients not only an indicator for renal dysfunction in patients with overt nephropathy but also a predictor for cardiovascular e- vents in patients without nephropathy显示文摘	Ogawa Y Goto T Tamasawa N	2008	Diabetes Research and Clinical Practice2008，79，2：	1
16	Plasma levels of soluble vascular adhesion molecular-1 and cholesmml oxidation product in type 2 diabetic patients with nephropathy显示文摘	Tamasawa N Matsul J	2001	J Atheroscler Thromb2001，8，：	1
17	Effects of combined PPARgamma an-d PPARalpha agonist therapy on reverse cholesterol transport in the Zucker diab-etic fatty rat显示文摘	Tanabe J Tamasawa N Yamashita M	2008	Diabetes Obes Metab2008，10，9：	1
18	Effects of sitagliptin or mitiglinide as an add-on to acarbose on daily blood glucose fluctuations measured by 72 h subcutaneous continuous glucose monitoring in Japanese patients with type 2 diabetes: a prospective randomized study显示文摘	Osonoi T Saito M Tamasawa A	2014	Expert Opin Pharmacother2014，15，10：	1
19	Serum cystatin C in diabetic patients显示文摘	Yoshiji Ogawa Takashi Goto Naoki Tamasawa Jun Matsui Yusuke Tando Kazuhiro Sugimoto Ken Tomotsune Masahiko Kimura Minoru Yasujima Toshihiro Suda	2007	Diabetes Research and Clinical Practice2007，，2：	1
20	Clofibrate, aperoxi some proliferator, enhances reverse cholesterol transport through cytochrome p450 activation and oxysterol generation 显示文摘	Guan j Z Tamasawa N Murakami H	2003	J Exp Med2003，201，4：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示